Action Pharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Action Pharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					               Action Pharma A/S - Pharmaceuticals & Healthcare - Deals and Alliances
                                             Profile
       Reference Code: GDPH140691D                                                                                                           Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      Action Pharma A/S (Action Pharma) is a biotechnology company, based in
                                                                                                              Action Pharma A/S, Pharmaceuticals & Healthcare,
      Denmark. It discovers and develops new drugs and treatment concepts to treat
                                                                                                              Key Facts
      cardiovascular disease and inflammatory diseases, as well as metabolic diseases,
      such as type-II diabetes and obesity. The product pipeline of the company includes                       Web Address                      www.actionpharma.com
      AP1030, an oral anti-diabetic (OAD) for the treatment of type-II diabetes associated
                                                                                                               Revenue (US$ million)                            NA
      with overweight/obesity; and AP214, a modified DMSH-peptide analogue to treat
      post-surgical kidney injury associated with cardiac surgery. Action Pharma also                          Number of Employees                              NA
      develops AP1189, an oral anti-inflammatory compound to treat inflammatory                                GlobalData
      diseases, such as inflammatory bowel disease and rheumatoid arthritis.

      Financial Deals Landscape
        Action Pharma A/S, Pharmaceuticals & Healthcare, Deals by                         Action Pharma A/S, Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                          1              1                1
                                                                                                          1


                                                                                           No. of Deals



                                                                                                                 0                  0           0                   0
                                                                                                          0
                                                                                                               2007      2008   2009    2010   2011     2012     YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Action Pharma A/S, Pharmaceuticals & Healthcare, Deals                           Action Pharma A/S, Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013
                                                                                           No. of D…




                         3                                                                                3
          No. of Deals




                                                                                                                     3          2        2          2           2
                               3
                                                                                                          2
                         2
                                        1         1        1         1                                    1
                         1                                                                                0
                                                                                                                Genito Cardiov Dermat           Gastroi       Immun
                         0                                                                                      Urinary ascular ology           ntestin        ology
                             Europe   Asia-     Middle   North    South                                         System                             al
                                      Pacific    East    Americ    and                                           And
                                                 and       a      Central                                        Sex
                                                Africa            Americ                                        Hormo
                                                                    a                                            nes



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Action Pharma A/S - Pharmaceuticals & Healthcare - Deals and                                                                                   Reference Code: GDPH140691D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Action Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 4
       Action Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .................................................................... 5
       Action Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................... 6
       Action Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ..................................................... 7
       Action Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................. 8
       Action Pharma A/S, Pharmaceuticals & Healthcare, Deal Details ...................................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             Action Pharma Secures $6.1 Million In Series C Venture Financing ........................................................................................... 9
             Action Pharma Secures $22 Million In Series D Financing Round ............................................................................................ 11
          Asset Transactions ....................................................................................................................................................................... 13
             Abbott Labs Acquires AP214 From Action Pharma For $110 Million ........................................................................................ 13
       Action Pharma A/S - Key Competitors ............................................................................................................................................. 15
       Key Employees ................................................................................................................................................................................ 16
       Locations And Subsidiaries .............................................................................................................................................................. 17
          Head Office ................................................................................................................................................................................... 17
       Appendix .......................................................................................................................................................................................... 18
          Methodology ................................................................................................................................................................................. 18
          About GlobalData .....................................................................
				
DOCUMENT INFO
Description: Action Pharma A/S (Action Pharma) is a biotechnology company, based in Denmark. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The product pipeline of the company includes AP1030, an oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity; and AP214, a modified DMSH-peptide analogue to treat post-surgical kidney injury associated with cardiac surgery. Action Pharma also develops AP1189, an oral anti-inflammatory compound to treat inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis. It also offers AP405, which is a modified MSH peptide analogue to treat inflammatory skin diseases such as atopic dermatitis. Action Pharma is headquartered in Arhus, Denmark.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.